文献速递肿瘤 PET/CT甲状腺核医学

[18F]AlF-NOTA-FAPI-04 PET/CT 提高分化型甲状腺癌亚厘米复发灶的检出

[18F]AlF-NOTA-FAPI-04 PET/CT improves detection of subcentimeter recurrent lesions in differentiated thyroid cancer.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-07-15

研究纳入 23 例生化复发分化型甲状腺癌(DTC)患者,行 [18F]AlF-NOTA-FAPI-04 PET/CT,其中 16 例有配对 [18F]FDG PET/CT。FAPI 在病灶水平敏感度(75% vs 13%,P=0.002)和准确率(80% vs 27%,P<0.001)均高于 FDG,患者水平敏感度达 100%(7/7 vs 14%[1/7],P=0.003)。

要点

  • 病灶水平敏感度 FAPI 75% vs FDG 13%(P=0.002),准确率 80% vs 27%(P<0.001)。
  • 患者水平敏感度 FAPI 100%(7/7)vs FDG 14%(1/7),P=0.003。
  • 7 枚颈部淋巴结转移(平均直径 5.9±1.4 mm)仅由 FAPI 检出。

核心结论

  • [18F]AlF-NOTA-FAPI-04 PET/CT 在检出复发 DTC 小转移灶方面诊断效能优于 [18F]FDG PET/CT,可能有助于早期干预和改善患者管理。

研究设计与样本

  • 研究纳入 23 例生化复发 DTC 患者(抑制性 Tg≥1 ng/mL 或 Tg-Ab>115 IU/mL),行 [18F]AlF-NOTA-FAPI-04 PET/CT,其中 16 例接受配对 [18F]FDG 扫描。
  • 病灶分类依据组织病理学或中位 15.5 个月(范围 8-32 个月)的临床随访。

主要发现

  • 病灶水平敏感度 FAPI 75% vs FDG 13%(P=0.002),准确率 FAPI 80% vs FDG 27%(P<0.001)。
  • 患者水平敏感度 FAPI 100%(7/7)vs FDG 14%(1/7),P=0.003。
  • 7 枚颈部淋巴结转移(平均直径 5.9±1.4 mm)仅由 FAPI 显像检出。

临床怎么用

  • 原文结论认为 [18F]AlF-NOTA-FAPI-04 PET/CT 在复发 DTC 小转移灶检出方面诊断效能优于 [18F]FDG PET/CT,可能有助于早期干预和改善患者管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Fibroblast activation protein (FAP)-targeted PET/CT has emerged as a promising tool for visualizing tumor stroma. This study aimed to validate the diagnostic efficacy of [18F]AlF-NOTA-FAPI-04 PET/CT in detecting subclinical metastases in recurrent differentiated thyroid cancer (DTC), with direct comparison to [18F]FDG PET/CT. METHODS: Twenty-three DTC participants with biochemical recurrence (suppressed thyroglobulin [Tg] ≥ 1 ng/mL or Tg antibodies [Tg-Ab] > 115 IU/mL) underwent [18F]AlF-NOTA-FAPI-04 PET/CT, including 16 who underwent paired [18F]FDG scans. Lesion classification followed histopathology or 15.5-month clinical follow-up (median, 8-32 months). RESULTS: [18F]AlF-NOTA-FAPI-04 PET/CT demonstrated significantly higher lesion-level sensitivity (75% vs. 13%, P = 0.002) and accuracy (80% vs. 27%, P < 0.001) than [18F]FDG. Participant-level sensitivity reached 100% (7/7 vs. 14% [1/7], P = 0.003). Notably, 7 cervical lymph node metastases (mean diameter 5.9 ± 1.4 mm) were detected exclusively by FAPI imaging. CONCLUSION: [18F]AlF-NOTA-FAPI-04 PET/CT exhibits superior diagnostic performance over [18F]FDG PET/CT in detecting small metastatic lesions in recurrent DTC, potentially enabling earlier intervention and improved patient management.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Zheng K, Zhou W, Yang J, et al. [18F]AlF-NOTA-FAPI-04 PET/CT improves detection of subcentimeter recurrent lesions in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2025. PMID: 40663160. doi:10.1007/s00259-025-07433-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。